Physician Wealth Advisors Inc. Invests $64,000 in HCA Healthcare, Inc. (NYSE:HCA)

Physician Wealth Advisors Inc. acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 4th quarter, Holdings Channel reports. The fund acquired 214 shares of the company’s stock, valued at approximately $64,000.

Other hedge funds have also recently modified their holdings of the company. Townsquare Capital LLC lifted its holdings in shares of HCA Healthcare by 12.8% in the 3rd quarter. Townsquare Capital LLC now owns 2,687 shares of the company’s stock valued at $1,092,000 after purchasing an additional 305 shares during the last quarter. Glenmede Trust Co. NA boosted its holdings in shares of HCA Healthcare by 4.4% in the third quarter. Glenmede Trust Co. NA now owns 3,022 shares of the company’s stock valued at $1,228,000 after acquiring an additional 128 shares during the period. Rockefeller Capital Management L.P. raised its position in HCA Healthcare by 1.9% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 23,090 shares of the company’s stock valued at $9,380,000 after purchasing an additional 440 shares during the last quarter. Centiva Capital LP grew its position in HCA Healthcare by 37.4% during the 3rd quarter. Centiva Capital LP now owns 13,264 shares of the company’s stock worth $5,391,000 after purchasing an additional 3,612 shares during the last quarter. Finally, Holocene Advisors LP lifted its position in HCA Healthcare by 210.6% during the 3rd quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock worth $124,691,000 after acquiring an additional 208,015 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on HCA shares. Truist Financial lowered their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Cantor Fitzgerald restated an “overweight” rating and set a $405.00 target price on shares of HCA Healthcare in a research report on Monday, January 27th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a report on Tuesday, December 17th. Barclays decreased their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research report on Monday, January 27th. Finally, Morgan Stanley reduced their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

Insider Transactions at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Trading Up 1.1 %

NYSE HCA opened at $346.08 on Tuesday. The company has a 50-day moving average of $325.24 and a 200-day moving average of $340.60. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a market cap of $85.20 billion, a P/E ratio of 15.75, a P/E/G ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the firm posted $5.90 earnings per share. As a group, equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were issued a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.83%. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.